Market Research Industry Reports

Sunglasses in France

  • DESCRIPTION
  • TABLE OF CONTENTS
  • RELATED REPORTS
  • SAMPLE REQUEST
  • REVIEWS
Sunglasses in France saw a negligible decline in current value terms in 2018. Although the category is driven by and dominated by leading groups such as Luxottica France and Safilo France, it is increasingly challenged by smaller players offering cheaper options. The value decline can also be explained by many optical shops offering an extra pair of sunglasses at a reduced price in order to drive volume sales. Over the forecast period, sales of sunglasses are expected to continue declining in va...

The Internationals Sunglasses in France report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data (2013-2017), allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market be they new product developments, distribution or pricing issues. Forecasts to 2022 illustrate how the market is set to change.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Sunglasses market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the markets major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.


SUNGLASSES IN FRANCE



LIST OF CONTENTS AND TABLES

Headlines
Prospects
Sunglasses Remains Fairly Stable, With Value Sales Slightly Challenged
More Than Just An Accessory, Sunglasses Are the Advertising Arm of Luxury Brands
Luxury Brands Are Looking To Take Back Ownership of Their Own Brands
Competitive Landscape
Sales Remain Concentrated in the Hands of Big Groups
A Distribution Landscape Seeking Equilibrium Between "phygital"
Category Data
Table 1 Sales of Sunglasses: Volume 2013-2018
Table 2 Sales of Sunglasses: Value 2013-2018
Table 3 Sales of Sunglasses: % Volume Growth 2013-2018
Table 4 Sales of Sunglasses: % Value Growth 2013-2018
Table 5 NBO Company Shares of Sunglasses: % Value 2013-2017
Table 6 LBN Brand Shares of Sunglasses: % Value 2014-2017
Table 7 Distribution of Sunglasses by Format: % Value 2013-2018
Table 8 Forecast Sales of Sunglasses: Volume 2018-2023
Table 9 Forecast Sales of Sunglasses: Value 2018-2023
Table 10 Forecast Sales of Sunglasses: % Volume Growth 2018-2023
Table 11 Forecast Sales of Sunglasses: % Value Growth 2018-2023
Executive Summary
Eyewear Remains Strong in France, Despite A Slight Slowdown in Value Growth
After Years of Steady Growth, Eyewear Experiences A Value Sales Slump
Spectacles Remains Fragmented, Whilst Contact Lenses Is More Concentrated
the Need To Embrace A "phygital" Business Model
New French Legislation Is Expected To Impact Consumption Patterns
Market Data
Table 12 Sales of Eyewear by Category: Volume 2013-2018
Table 13 Sales of Eyewear by Category: Value 2013-2018
Table 14 Sales of Eyewear by Category: % Volume Growth 2013-2018
Table 15 Sales of Eyewear by Category: % Value Growth 2013-2018
Table 16 NBO Company Shares of Eyewear: % Value 2013-2017
Table 17 LBN Brand Shares of Eyewear: % Value 2014-2017
Table 18 Distribution of Eyewear by Format: % Value 2013-2018
Table 19 Forecast Sales of Eyewear by Category: Volume 2018-2023
Table 20 Forecast Sales of Eyewear by Category: Value 2018-2023
Table 21 Forecast Sales of Eyewear by Category: % Volume Growth 2018-2023
Table 22 Forecast Sales of Eyewear by Category: % Value Growth 2018-2023
Definitions
Sources
Summary 1 Research Sources













Tricida Inc (TCDA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Tricida Inc (Tricida), formerly Trilypsa Inc is a clinical-stage pharmaceutical and drug discovery company. The company discovers and develops novel non-absorbed therapies for the treatment of renal, metabolic and cardiovascular

USD 250View Report

Elsalys Biotech SA - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Elsalys Biotech SA (Elsalys Biotech) is a pharmaceutical company that develops new generation antibodies to modulate the immune system of patients with cancer or rare haematological diseases. The companys pipeline

USD 250View Report

Tricida Inc (TCDA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Tricida Inc (Tricida), formerly Trilypsa Inc is a clinical-stage pharmaceutical and drug discovery company. The company discovers and develops novel non-absorbed therapies for the treatment of renal, metabolic and cardiovascular

USD 250View Report

Elsalys Biotech SA - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Elsalys Biotech SA (Elsalys Biotech) is a pharmaceutical company that develops new generation antibodies to modulate the immune system of patients with cancer or rare haematological diseases. The companys pipeline

USD 250View Report

Your are not allow to send sample request
Fill The Form For Sample Request
Full Name :*
Bussiness Email: *
Email: *
Country :*
Contact No.*
Alternate No.
Note.:*Kindly provide us with your company id and get the sample reports at the earliest.
There is no Reviews available

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

  • PDF    USD 990
$ 990

Reports Details

Published Date : Jul 2018
No. of Pages :12
Country :France
Category :Personal Care
Publisher :Euromonitor
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

  • fb
  • twitter
  • pinterest
  • linckedin
  • rss
  • youtube